Inventor · disambiguated record
Swaminathan Natarajan
Also filed as: NATARAJAN SWAMINATHAN · NATARAJAN SWAMINATHAN R · NATARAJAN SWAMINATHAN RAVI
8 granted patents·4 pending applications·71 citations·filing 2001–2011
83Inventor score
Top patents by PatentIndex Score
12 records- 0189US6809199B2(Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agentsMERCK & CO INC·Filed 2001·Granted Oct 26, 2004·47 cites·40 claims
- 0280US7196082B2Ophthalmic compositions for treating ocular hypertensionMERCK & CO INC·Filed 2003·Granted Mar 27, 2007·14 cites·8 claims
- 0374US7547720B2Ophthalmic compositions for treating ocular hypertensionMERCK & CO INC·Filed 2006·Granted Jun 16, 2009·2 cites·4 claims
- 0466US7528163B2Ophthalmic compositions for treating ocular hypertensionMERCK & CO INC·Filed 2003·Granted May 5, 2009·3 cites·7 claims
- 0565US7494983B2Ophthalmic compositions for treating ocular hypertensionMERCK & CO INC·Filed 2004·Granted Feb 24, 2009·3 cites·14 claims
- 0661US7410992B2Ophthalmic compositions for treating ocular hypertensionMERCK & CO INC·Filed 2004·Granted Aug 12, 2008·1 cites·8 claims
- 0761US7314873B2(Halo-benzo carbonyl)heterobi cyclic p38 linase inhibiting agentsMERCK & CO INC·Filed 2003·Granted Jan 1, 2008·1 cites·12 claims
- 0848US7879875B2P38 kinase inhibiting agentsMERK SHARP & DOHME CORP·Filed 2006·Granted Feb 1, 2011·0 cites·7 claims
- 0944US2009281154A1Ophthalmic Compositions for Treating Ocular HypertensionDOHERTY JAMES B·Filed 2007·Application pending·0 cites
- 1043US2006148805A1Opthalmic compositions for treating ocular hypertensionCHEN MENG HSIN·Filed 2004·Application pending·0 cites
- 1142US2011183959A1P38 kinase inhibiting agentsCHEN MENG-HSIN·Filed 2011·Application pending·0 cites
- 1241US2006154897A1Ophthalmic compositions for treating ocular hypertensionDOHERTY JAMES B·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Swaminathan Natarajan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →